DeLucia R, Planeta C da S, Scavone C, Aizenstein M L
Gen Pharmacol. 1987;18(1):21-3. doi: 10.1016/0306-3623(87)90163-7.
Fencamfamine (1.0-10.0 mg/kg, i.p. single dose) reduced the food intake in a dose-effect relationship. The dose needed for the 50% inhibition of food intake (ID50) was 7.3 mg/kg. Fencamfamine-induced anorexia in rats (5.0 and 10.0 mg/kg) was followed by hyperactivity, stereotypy or both. Pretreatment with haloperidol antagonized the anoretic effect induced by fencamfamine. These findings suggest that the activation of central dopaminergic systems involved in feeding regulation may be responsible for the anoretic effect of fencamfamine and that this effect is associated with other central stimulant effects.
芬坎法明(腹腔注射单剂量1.0 - 10.0毫克/千克)可使食物摄入量呈剂量效应关系减少。抑制50%食物摄入量所需的剂量(半数抑制剂量,ID50)为7.3毫克/千克。大鼠腹腔注射芬坎法明(5.0和10.0毫克/千克)引起厌食后,会出现多动、刻板行为或两者皆有。氟哌啶醇预处理可拮抗芬坎法明诱导的厌食效应。这些发现表明,参与进食调节的中枢多巴胺能系统的激活可能是芬坎法明厌食效应的原因,且这种效应与其他中枢兴奋效应相关。